DECR2 Antibodies

Santa Cruz Biotechnology features a diverse variety of DECR2 monoclonal antibodies for research focused on understanding DECR2 protein function. DECR2 Antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DECR2, or 2,4-dienoyl-CoA reductase 2, is an essential enzyme involved in the metabolism of unsaturated fatty acids, playing a critical role in lipid metabolism and energy homeostasis. DECR2 maintains cellular health and regulates metabolic pathways, making it a significant target for studies related to metabolic disorders and cardiovascular diseases. Research focused on DECR2 can reveal potential therapeutic strategies for various health conditions. DECR2 Antibodies targeting DECR2 enable precise detection and analysis of expression patterns across different tissues and cellular compartments. Researchers can investigate DECR2's role in fatty acid metabolism through multiple experimental approaches. Understanding DECR2's regulatory mechanisms provides valuable insights into metabolic disease progression and potential treatments. Santa Cruz Biotechnology monoclonal antibodies for DECR2 support researchers worldwide in advancing scientific knowledge of metabolic pathways and disease mechanisms.